-
1
-
-
23844451664
-
Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by Semliki Forest virus
-
Forsell MN, Li Y, Sundback M, Svehla K, Liljestrom P, Mascola JR, Wyatt R, Karlsson Hedestam GB. 2005. Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by Semliki Forest virus. J Virol 79: 10902-10914. http://dx.doi.org/10.1128/JVI.79.17.10902-10914.2005.
-
(2005)
J Virol
, vol.79
, pp. 10902-10914
-
-
Forsell, M.N.1
Li, Y.2
Sundback, M.3
Svehla, K.4
Liljestrom, P.5
Mascola, J.R.6
Wyatt, R.7
Karlsson Hedestam, G.B.8
-
2
-
-
0027462887
-
Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein
-
Cooney EL, McElrath MJ, Corey L, Hu SL, Collier AC, Arditti D, Hoffman M, Coombs RW, Smith GE, Greenberg PD. 1993. Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein. Proc Natl Acad Sci U S A 90:1882-1886. http://dx.doi.org/10.1073/pnas.90.5.1882.
-
(1993)
Proc Natl Acad Sci U S A
, vol.90
, pp. 1882-1886
-
-
Cooney, E.L.1
McElrath, M.J.2
Corey, L.3
Hu, S.L.4
Collier, A.C.5
Arditti, D.6
Hoffman, M.7
Coombs, R.W.8
Smith, G.E.9
Greenberg, P.D.10
-
3
-
-
33846087269
-
Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs
-
Shu Y, Winfrey S, Yang ZY, Xu L, Rao SS, Srivastava I, Barnett SW, Nabel GJ, Mascola JR. 2007. Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs. Vaccine 25:1398-1408. http://dx.doi.org/10.1016/j.vaccine.2006.10.046.
-
(2007)
Vaccine
, vol.25
, pp. 1398-1408
-
-
Shu, Y.1
Winfrey, S.2
Yang, Z.Y.3
Xu, L.4
Rao, S.S.5
Srivastava, I.6
Barnett, S.W.7
Nabel, G.J.8
Mascola, J.R.9
-
4
-
-
33846224780
-
Characterization of immune responses elicited in macaques immunized sequentially with chimeric VEE/SIN alphavirus replicon particles expressing SIVGag and/or HIVEnv and with recombinant HIVgp140Env protein
-
Xu R, Srivastava IK, Greer CE, Zarkikh I, Kraft Z, Kuller L, Polo JM, Barnett SW, Stamatatos L. 2006. Characterization of immune responses elicited in macaques immunized sequentially with chimeric VEE/SIN alphavirus replicon particles expressing SIVGag and/or HIVEnv and with recombinant HIVgp140Env protein. AIDS Res Hum Retroviruses 22: 1022-1030. http://dx.doi.org/10.1089/aid.2006.22.1022.
-
(2006)
AIDS Res Hum Retroviruses
, vol.22
, pp. 1022-1030
-
-
Xu, R.1
Srivastava, I.K.2
Greer, C.E.3
Zarkikh, I.4
Kraft, Z.5
Kuller, L.6
Polo, J.M.7
Barnett, S.W.8
Stamatatos, L.9
-
5
-
-
0142154176
-
Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease
-
Fultz PN, Stallworth J, Porter D, Novak M, Anderson MJ, Morrow CD. 2003. Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease. Virology 315:425-437. http://dx.doi.org/10.1016/S0042-6822(03)00546-4.
-
(2003)
Virology
, vol.315
, pp. 425-437
-
-
Fultz, P.N.1
Stallworth, J.2
Porter, D.3
Novak, M.4
Anderson, M.J.5
Morrow, C.D.6
-
6
-
-
77952688015
-
Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant
-
Barnett SW, Burke B, Sun Y, Kan E, Legg H, Lian Y, Bost K, Zhou F, Goodsell A, Zur Megede J, Polo J, Donnelly J, Ulmer J, Otten GR, Miller CJ, Vajdy M, Srivastava IK. 2010. Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant. J Virol 84:5975-5985. http://dx.doi.org/10.1128/JVI.02533-09.
-
(2010)
J Virol
, vol.84
, pp. 5975-5985
-
-
Barnett, S.W.1
Burke, B.2
Sun, Y.3
Kan, E.4
Legg, H.5
Lian, Y.6
Bost, K.7
Zhou, F.8
Goodsell, A.9
Zur Megede, J.10
Polo, J.11
Donnelly, J.12
Ulmer, J.13
Otten, G.R.14
Miller, C.J.15
Vajdy, M.16
Srivastava, I.K.17
-
7
-
-
84937950533
-
HIV-1 vaccines. Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
-
Barouch DH, Alter G, Broge T, Linde C, Ackerman ME, Brown EP, Borducchi EN, Smith KM, Nkolola JP, Liu J, Shields J, Parenteau L, Whitney JB, Abbink P, Ng'ang'a DM, Seaman MS, Lavine CL, Perry JR, Li W, Colantonio AD, Lewis MG, Chen B, Wenschuh H, Reimer U, Piatak M, Lifson JD, Handley SA, Virgin HW, Koutsoukos M, Lorin C, Voss G, Weijtens M, Pau MG, Schuitemaker H. 2015. HIV-1 vaccines. Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys. Science 349:320-324.
-
(2015)
Science
, vol.349
, pp. 320-324
-
-
Barouch, D.H.1
Alter, G.2
Broge, T.3
Linde, C.4
Ackerman, M.E.5
Brown, E.P.6
Borducchi, E.N.7
Smith, K.M.8
Nkolola, J.P.9
Liu, J.10
Shields, J.11
Parenteau, L.12
Whitney, J.B.13
Abbink, P.14
Ng'ang'a, D.M.15
Seaman, M.S.16
Lavine, C.L.17
Perry, J.R.18
Li, W.19
Colantonio, A.D.20
Lewis, M.G.21
Chen, B.22
Wenschuh, H.23
Reimer, U.24
Piatak, M.25
Lifson, J.D.26
Handley, S.A.27
Virgin, H.W.28
Koutsoukos, M.29
Lorin, C.30
Voss, G.31
Weijtens, M.32
Pau, M.G.33
Schuitemaker, H.34
more..
-
8
-
-
73349094086
-
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
-
Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361: 2209-2220. http://dx.doi.org/10.1056/NEJMoa0908492.
-
(2009)
N Engl J Med
, vol.361
, pp. 2209-2220
-
-
Rerks-Ngarm, S.1
Pitisuttithum, P.2
Nitayaphan, S.3
Kaewkungwal, J.4
Chiu, J.5
Paris, R.6
Premsri, N.7
Namwat, C.8
de Souza, M.9
Adams, E.10
Benenson, M.11
Gurunathan, S.12
Tartaglia, J.13
McNeil, J.G.14
Francis, D.P.15
Stablein, D.16
Birx, D.L.17
Chunsuttiwat, S.18
Khamboonruang, C.19
Thongcharoen, P.20
Robb, M.L.21
Michael, N.L.22
Kunasol, P.23
Kim, J.H.24
more..
-
9
-
-
27144444664
-
Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates
-
Bukreyev A, Huang Z, Yang L, Elankumaran S, St Claire M, Murphy BR, Samal SK, Collins PL. 2005. Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. J Virol 79:13275-13284. http://dx.doi.org/10.1128/JVI.79.21.13275-13284.2005.
-
(2005)
J Virol
, vol.79
, pp. 13275-13284
-
-
Bukreyev, A.1
Huang, Z.2
Yang, L.3
Elankumaran, S.4
St Claire, M.5
Murphy, B.R.6
Samal, S.K.7
Collins, P.L.8
-
10
-
-
34547406849
-
Newcastle disease virus, a host rangerestricted virus, as a vaccine vector for intranasal immunization against emerging pathogens
-
DiNapoli JM, Kotelkin A, Yang L, Elankumaran S, Murphy BR, Samal SK, Collins PL, Bukreyev A. 2007. Newcastle disease virus, a host rangerestricted virus, as a vaccine vector for intranasal immunization against emerging pathogens. Proc Natl Acad Sci U S A 104:9788-9793. http://dx.doi.org/10.1073/pnas.0703584104.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 9788-9793
-
-
DiNapoli, J.M.1
Kotelkin, A.2
Yang, L.3
Elankumaran, S.4
Murphy, B.R.5
Samal, S.K.6
Collins, P.L.7
Bukreyev, A.8
-
11
-
-
73949090729
-
Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys
-
DiNapoli JM, Nayak B, Yang L, Finneyfrock BW, Cook A, Andersen H, Torres-Velez F, Murphy BR, Samal SK, Collins PL, Bukreyev A. 2010. Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. J Virol 84:1489-1503. http://dx.doi.org/10.1128/JVI.01946-09.
-
(2010)
J Virol
, vol.84
, pp. 1489-1503
-
-
DiNapoli, J.M.1
Nayak, B.2
Yang, L.3
Finneyfrock, B.W.4
Cook, A.5
Andersen, H.6
Torres-Velez, F.7
Murphy, B.R.8
Samal, S.K.9
Collins, P.L.10
Bukreyev, A.11
-
12
-
-
78649697847
-
Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
-
DiNapoli JM, Yang L, Samal SK, Murphy BR, Collins PL, Bukreyev A. 2010. Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response. Vaccine 29:17-25. http://dx.doi.org/10.1016/j.vaccine.2010.10.024.
-
(2010)
Vaccine
, vol.29
, pp. 17-25
-
-
DiNapoli, J.M.1
Yang, L.2
Samal, S.K.3
Murphy, B.R.4
Collins, P.L.5
Bukreyev, A.6
-
13
-
-
35448972595
-
Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus
-
DiNapoli JM, Yang L, Suguitan A, Jr, Elankumaran S, Dorward DW, Murphy BR, Samal SK, Collins PL, Bukreyev A. 2007. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J Virol 81:11560-11568. http://dx.doi.org/10.1128/JVI.00713-07.
-
(2007)
J Virol
, vol.81
, pp. 11560-11568
-
-
DiNapoli, J.M.1
Yang, L.2
Suguitan, A.3
Elankumaran, S.4
Dorward, D.W.5
Murphy, B.R.6
Samal, S.K.7
Collins, P.L.8
Bukreyev, A.9
-
14
-
-
84940870885
-
Mucosal immunization with Newcastle disease virus vector coexpressing HIV-1 Env and Gag proteins elicits potent serum, mucosal, and cellular immune responses that protect against vaccinia virus Env and Gag challenges
-
Khattar SK, Manoharan V, Bhattarai B, LaBranche CC, Montefiori DC, Samal SK. 2015. Mucosal immunization with Newcastle disease virus vector coexpressing HIV-1 Env and Gag proteins elicits potent serum, mucosal, and cellular immune responses that protect against vaccinia virus Env and Gag challenges. mBio 6:e01005. http://dx.doi.org/10.1128/mBio.01005-15.
-
(2015)
mBio
, vol.6
-
-
Khattar, S.K.1
Manoharan, V.2
Bhattarai, B.3
LaBranche, C.C.4
Montefiori, D.C.5
Samal, S.K.6
-
15
-
-
84929091266
-
Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus
-
Khattar SK, Palaniyandi S, Samal S, LaBranche CC, Montefiori DC, Zhu X, Samal SK. 2015. Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus. Hum Vaccin Immunother 11:504-515. http://dx.doi.org/10.4161/21645515.2014.987006.
-
(2015)
Hum Vaccin Immunother
, vol.11
, pp. 504-515
-
-
Khattar, S.K.1
Palaniyandi, S.2
Samal, S.3
LaBranche, C.C.4
Montefiori, D.C.5
Zhu, X.6
Samal, S.K.7
-
16
-
-
80055018755
-
Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigs
-
Khattar SK, Samal S, Devico AL, Collins PL, Samal SK. 2011. Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigs. J Virol 85:10529-10541. http://dx.doi.org/10.1128/JVI.05050-11.
-
(2011)
J Virol
, vol.85
, pp. 10529-10541
-
-
Khattar, S.K.1
Samal, S.2
Devico, A.L.3
Collins, P.L.4
Samal, S.K.5
-
17
-
-
84884858409
-
Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated Newcastle disease virus vector
-
Khattar SK, Samal S, LaBranche CC, Montefiori DC, Collins PL, Samal SK. 2013. Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated Newcastle disease virus vector. PLoS One 8:e78521. http://dx.doi.org/10.1371/journal.pone.0078521.
-
(2013)
PLoS One
, vol.8
-
-
Khattar, S.K.1
Samal, S.2
LaBranche, C.C.3
Montefiori, D.C.4
Collins, P.L.5
Samal, S.K.6
-
18
-
-
84861307180
-
Signature biochemical properties of broadly cross-reactive HIV-1 neutralizing antibodies in human plasma
-
Sajadi MM, Lewis GK, Seaman MS, Guan Y, Redfield RR, DeVico AL. 2012. Signature biochemical properties of broadly cross-reactive HIV-1 neutralizing antibodies in human plasma. J Virol 86:5014-5025. http://dx.doi.org/10.1128/JVI.06547-11.
-
(2012)
J Virol
, vol.86
, pp. 5014-5025
-
-
Sajadi, M.M.1
Lewis, G.K.2
Seaman, M.S.3
Guan, Y.4
Redfield, R.R.5
DeVico, A.L.6
-
19
-
-
33847293391
-
Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1
-
Dey AK, David KB, Klasse PJ, Moore JP. 2007. Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1. Virology 360:199-208. http://dx.doi.org/10.1016/j.virol.2006.09.046.
-
(2007)
Virology
, vol.360
, pp. 199-208
-
-
Dey, A.K.1
David, K.B.2
Klasse, P.J.3
Moore, J.P.4
-
20
-
-
84926442279
-
Antigenicity and immunogenicity of a trimeric envelope protein from an Indian clade C HIV-1 isolate
-
Sneha Priya R, Veena M, Kalisz I, Whitney S, Priyanka D, LaBranche CC, Sri Teja M, Montefiori DC, Pal R, Mahalingam S, Kalyanaraman VS. 2015. Antigenicity and immunogenicity of a trimeric envelope protein from an Indian clade C HIV-1 isolate. J Biol Chem 290:9195-9208. http://dx.doi.org/10.1074/jbc. M114.621185.
-
(2015)
J Biol Chem
, vol.290
, pp. 9195-9208
-
-
Sneha Priya, R.1
Veena, M.2
Kalisz, I.3
Whitney, S.4
Priyanka, D.5
LaBranche, C.C.6
Sri Teja, M.7
Montefiori, D.C.8
Pal, R.9
Mahalingam, S.10
Kalyanaraman, V.S.11
-
21
-
-
31144451337
-
Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants
-
Li Y, Svehla K, Mathy NL, Voss G, Mascola JR, Wyatt R. 2006. Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants. J Virol 80:1414-1426. http://dx.doi.org/10.1128/JVI.80.3.1414-1426.2006.
-
(2006)
J Virol
, vol.80
, pp. 1414-1426
-
-
Li, Y.1
Svehla, K.2
Mathy, N.L.3
Voss, G.4
Mascola, J.R.5
Wyatt, R.6
-
22
-
-
23244434512
-
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
-
Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, Koutsoukos M, Voss G, Goepfert P, Gilbert P, Greene KM, Bilska M, Kothe DL, Salazar-Gonzalez JF, Wei X, Decker JM, Hahn BH, Montefiori DC. 2005. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 79:10108-10125. http://dx.doi.org/10.1128/JVI.79.16.10108-10125.2005.
-
(2005)
J Virol
, vol.79
, pp. 10108-10125
-
-
Li, M.1
Gao, F.2
Mascola, J.R.3
Stamatatos, L.4
Polonis, V.R.5
Koutsoukos, M.6
Voss, G.7
Goepfert, P.8
Gilbert, P.9
Greene, K.M.10
Bilska, M.11
Kothe, D.L.12
Salazar-Gonzalez, J.F.13
Wei, X.14
Decker, J.M.15
Hahn, B.H.16
Montefiori, D.C.17
-
23
-
-
67650741139
-
Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1
-
Kang YK, Andjelic S, Binley JM, Crooks ET, Franti M, Iyer SP, Donovan GP, Dey AK, Zhu P, Roux KH, Durso RJ, Parsons TF, Maddon PJ, Moore JP, Olson WC. 2009. Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1. Vaccine 27:5120-5132. http://dx.doi.org/10.1016/j.vaccine.2009.06.037.
-
(2009)
Vaccine
, vol.27
, pp. 5120-5132
-
-
Kang, Y.K.1
Andjelic, S.2
Binley, J.M.3
Crooks, E.T.4
Franti, M.5
Iyer, S.P.6
Donovan, G.P.7
Dey, A.K.8
Zhu, P.9
Roux, K.H.10
Durso, R.J.11
Parsons, T.F.12
Maddon, P.J.13
Moore, J.P.14
Olson, W.C.15
-
24
-
-
33947590277
-
A comparative immunogenicity study in rabbits of disulfidestabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120
-
Beddows S, Franti M, Dey AK, Kirschner M, Iyer SP, Fisch DC, Ketas T, Yuste E, Desrosiers RC, Klasse PJ, Maddon PJ, Olson WC, Moore JP. 2007. A comparative immunogenicity study in rabbits of disulfidestabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120. Virology 360:329-340. http://dx.doi.org/10.1016/j.virol.2006.10.032.
-
(2007)
Virology
, vol.360
, pp. 329-340
-
-
Beddows, S.1
Franti, M.2
Dey, A.K.3
Kirschner, M.4
Iyer, S.P.5
Fisch, D.C.6
Ketas, T.7
Yuste, E.8
Desrosiers, R.C.9
Klasse, P.J.10
Maddon, P.J.11
Olson, W.C.12
Moore, J.P.13
-
25
-
-
0035155850
-
Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers
-
Yang X, Wyatt R, Sodroski J. 2001. Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers. J Virol 75:1165-1171. http://dx.doi.org/10.1128/JVI.75.3.1165-1171.2001.
-
(2001)
J Virol
, vol.75
, pp. 1165-1171
-
-
Yang, X.1
Wyatt, R.2
Sodroski, J.3
-
26
-
-
4444342579
-
Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d
-
Bower JF, Yang X, Sodroski J, Ross TM. 2004. Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d. J Virol 78:4710-4719. http://dx.doi.org/10.1128/JVI.78.9.4710-4719.2004.
-
(2004)
J Virol
, vol.78
, pp. 4710-4719
-
-
Bower, J.F.1
Yang, X.2
Sodroski, J.3
Ross, T.M.4
-
27
-
-
84937469192
-
HIV-1 vaccines. HIV-1 neutralizing antibodies induced by native-like envelope trimers
-
Sanders RW, van Gils MJ, Derking R, Sok D, Ketas TJ, Burger JA, Ozorowski G, Cupo A, Simonich C, Goo L, Arendt H, Kim HJ, Lee JH, Pugach P, Williams M, Debnath G, Moldt B, van Breemen MJ, Isik G, Medina-Ramirez M, Back JW, KoffWC, Julien JP, Rakasz EG, Seaman MS, Guttman M, Lee KK, Klasse PJ, LaBranche C, Schief WR, Wilson IA, Overbaugh J, Burton DR, Ward AB, Montefiori DC, Dean H, Moore JP. 2015. HIV-1 vaccines. HIV-1 neutralizing antibodies induced by native-like envelope trimers. Science 349:aac4223.
-
(2015)
Science
, vol.349
-
-
Sanders, R.W.1
van Gils, M.J.2
Derking, R.3
Sok, D.4
Ketas, T.J.5
Burger, J.A.6
Ozorowski, G.7
Cupo, A.8
Simonich, C.9
Goo, L.10
Arendt, H.11
Kim, H.J.12
Lee, J.H.13
Pugach, P.14
Williams, M.15
Debnath, G.16
Moldt, B.17
van Breemen, M.J.18
Isik, G.19
Medina-Ramirez, M.20
Back, J.W.21
Koff, W.C.22
Julien, J.P.23
Rakasz, E.G.24
Seaman, M.S.25
Guttman, M.26
Lee, K.K.27
Klasse, P.J.28
LaBranche, C.29
Schief, W.R.30
Wilson, I.A.31
Overbaugh, J.32
Burton, D.R.33
Ward, A.B.34
Montefiori, D.C.35
Dean, H.36
Moore, J.P.37
more..
|